Content Rheum
Home
Faculty
Podcasts
Disease
Subscribe
X
Full Name
Email Address
Provider Type
Select Category
MD
DO
PA
NP
RN
MA
Dietician
Other
This field is required.
Subscribe
Reset
IL-23
IL-23
Back to Disease
All
FAQ Video Modules
Journal Club Video Modules
Medical Review Modules
Sort by
Oldest
Newest
What is the safety profile of guselkumab in PsO and PsA?
Medication
WATCH NOW
How does axial PsA differ from AS clinically, genetically, and radiographically
Faq
WATCH NOW
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Journal
WATCH NOW
Why is Binding CD64+ Important When Discussing IL23 Directed Therapy
Faq
WATCH NOW
How is Guselkumab dosed in PsO, PsA, and IBD
Medication
WATCH NOW
Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.
Faq
WATCH NOW
What is The Role of IL23/IL17 Axis in Rheumatic Disease
Faq
WATCH NOW
Describe the IL23/IL17 Axis
Faq
WATCH NOW
Describe The Mechanism of Action of Guselkumab
Medication
WATCH NOW
Define, Compare, and Contrast Humoral and Cell-Mediated Immunity
Faq
WATCH NOW
Download the app and start using it now.
Download on the
App Store
GET IT ON
Google Play